Search Ontology:
ChEBI
osimertinib mesylate
- Term ID
- CHEBI:90948
- Synonyms
-
- AZD9291 mesylate
- N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide methanesulfonate
- osimertinib mesilate
- osimertinib mesylate
- osimertinib methanesulfonate
- osimertinib monomesylate
- Tagrisso
- Definition
- A methanesulfonate (mesylate) salt prepared from equimolar amounts of osimertinib and methanesulfonic acid. It is used for treatment of EGFR T790M mutation positive non-small cell lung cancer.
- References
-
- CAS:1421373-66-1
- KEGG:D10766
- PMID:26515464
- PMID:26620497
- PMID:26720284
- PMID:26720671
- PMID:26729184
- PMID:27641462
- PMID:27660466
- PMID:27923840
- PMID:28710746
- PMID:29180936
- PMID:29998228
- PMID:30073261
- PMID:30643560
- PMID:32211870
- PMID:33755621
- PMID:34156056
- PMID:34564820
- PMID:34723634
- Reaxys:23334374
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
-
Phenotype
Phenotype resulting from osimertinib mesylate
Phenotype where environments contain osimertinib mesylate
Phenotype modified by environments containing osimertinib mesylate
Human Disease Model